BIOGEN INC. Annual Operating Income (Loss) in USD from 2010 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Biogen Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2021.
  • Biogen Inc. Operating Income (Loss) for the quarter ending March 31, 2022 was $611M, a 37.3% decline year-over-year.
  • Biogen Inc. Operating Income (Loss) for the twelve months ending March 31, 2022 was $2.48B, a 33.1% decline year-over-year.
  • Biogen Inc. annual Operating Income (Loss) for 2021 was $2.84B, a 37.6% decline from 2020.
  • Biogen Inc. annual Operating Income (Loss) for 2020 was $4.55B, a 35.4% decline from 2019.
  • Biogen Inc. annual Operating Income (Loss) for 2019 was $7.04B, a 19.6% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $2.84B -$1.71B -37.6% Jan 1, 2021 Dec 31, 2021 10-K 2022-02-03
2020 $4.55B -$2.49B -35.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-03
2019 $7.04B +$1.15B +19.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-03
2018 $5.89B +$543M +10.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-03
2017 $5.35B +$194M +3.77% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-06
2016 $5.15B +$261M +5.33% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-06
2015 $4.89B +$919M +23.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-01
2014 $3.97B +$1.46B +57.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-02
2013 $2.52B +$660M +35.5% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-03
2012 $1.86B +$131M +7.61% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-04
2011 $1.72B +$476M +38.1% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-06
2010 $1.25B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.